RB

Rahul Bishnoi

Active Director Director DIN 07974384
DIN 07974384 First appointment Nov 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2017
Shareholding value •••• Premium profile

About Rahul Bishnoi

Data last updated:

Rahul Bishnoi is a Director at Slv Medisciences Private Limited (since 2017). The company operates in Healthcare. Slv Medisciences Private Limited reported revenue of ₹19 Lakh (FY 2020).

DIN 07974384
Primary Designation Director
Industry Healthcare
First Appointment 15 Nov 2017
Oldest Company Age 9 yrs
Largest company Slv Medisciences Private Limited · ₹19 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Slv Medisciences Private Limited U85100RJ2017PTC059504
Director15 Nov 20172017₹19 Lakh (FY 2020)Active

Board colleagues of Rahul Bishnoi

Directorship timeline

Open interactive timeline →
Slv Medisciences Private Limited
Premium access

Shareholding and investment profile for Rahul Bishnoi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Bishnoi

Rahul Bishnoi currently holds 1 directorship: Slv Medisciences Private Limited (Director, since 15 Nov 2017, revenue ₹19 Lakh (FY 2020)).

Rahul Bishnoi was first appointed on 15 Nov 2017 as Director at Slv Medisciences Private Limited.

The current boards of Rahul Bishnoi's companies include Khushaboo Agnihotri (Slv Medisciences Private Limited), Sonal Raghav (Slv Medisciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available